GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Eiko Lifesciences Ltd (BOM:540204) » Definitions » Debt-to-Revenue

Eiko Lifesciences (BOM:540204) Debt-to-Revenue : 0.01 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Eiko Lifesciences Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Eiko Lifesciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹4.3 Mil. Eiko Lifesciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹0.0 Mil. Eiko Lifesciences's annualized Revenue for the quarter that ended in Sep. 2024 was ₹326.2 Mil. Eiko Lifesciences's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.01.


Eiko Lifesciences Debt-to-Revenue Historical Data

The historical data trend for Eiko Lifesciences's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eiko Lifesciences Debt-to-Revenue Chart

Eiko Lifesciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.14 0.18 - -

Eiko Lifesciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - - 0.01

Competitive Comparison of Eiko Lifesciences's Debt-to-Revenue

For the Specialty Chemicals subindustry, Eiko Lifesciences's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eiko Lifesciences's Debt-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Eiko Lifesciences's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eiko Lifesciences's Debt-to-Revenue falls into.



Eiko Lifesciences Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Eiko Lifesciences's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 281.111
=0.00

Eiko Lifesciences's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(4.262 + 0) / 326.204
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Eiko Lifesciences Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eiko Lifesciences's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eiko Lifesciences Business Description

Traded in Other Exchanges
N/A
Address
604, Centrum, Wagle Estate, Opposite TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane, MH, IND, 400604
Eiko Lifesciences Ltd is a manufacturer of specialty and fine chemicals. The company mainly engaged in one segment that is in the field of Specialty and fine chemicals, and their related products.

Eiko Lifesciences Headlines

No Headlines